Acute Coronary Syndrome: Competitive Landscape to 2026

Acute Coronary Syndrome: Competitive Landscape to 2026

Summary

Acute coronary syndrome (ACS) refers to a spectrum of myocardial ischemic states caused by the disruption of atherosclerotic plaques in the coronary arteries. The syndrome is precipitated by coronary artery occlusion (stenosis), which results in ischemia and myocardial necrosis. The development of ACS is heavily influenced by diet and lifestyle, and can manifest as myocardial infarction (MI) or unstable angina (UA).

This report provides an assessment of the pipeline, clinical, and commercial landscape of ACS. Overall, GlobalData expects new drug approvals to drive ACS market growth over the next decade (2016-2026).

Scope

This report combines data from the Pharma Intelligence Center with in-house analyst expertise to provide a competitive assessment of the disease marketplace. Components of the slide deck include -
- Pipeline Assessment: regional breakdown, promising late-stage products, early-stage pipeline by molecule type
- Clinical Trials Assessment: trial breakdown by phase, leading industry and non-industry sponsors, enrollment analytics
- Commercial Assessment: leading marketed products, current and future players
- Competitive Landscape Analysis: key market events (2016-2026).

Reasons to buy

- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
- Develop business strategies by understanding the trends shaping and driving the global Acute Coronary Syndrome market.
- Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the global Acute Coronary Syndrome market in the future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
- Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.

1. Preface 2
1. 2
1.2 Abbreviations 3
1.3 Related Reports 4
1.4 Upcoming Related Reports 5
2. Executive Summary 6
2.2 Key Findings 7
2.2 Key Events 8
3. Introduction 9
3.1 Report Scope 10
3.2 Disease Overview and Epidemiology 12
4. Pipeline Assessment 15
4.1 Pipeline Overview 16
4.2 Pipeline Breakdown by Region/Country 18
4.3 Pipeline Breakdown by Molecule Type and Target 19
4.4 Drug Review Designations 20
4.5 Products in Clinical Development 21
5. Clinical Trial Assessment 23
5.1 Clinical Trials Overview 24
5.2 Top Sponsors of Clinical Trials in Acute Coronary Syndrome 25
5.3 Trial Breakdown by Region 27
5.4 Therapy Area Perspective 28
5.5 Enrollment Analytics 29
6 Commercial Assessment 32
6.1 Leading Marketed Products 33
6.2 Current & Future Players 34
7. Competitive Landscape Analysis (2016-2025) 35
7.1 Events Classification Overview 36
7.2 US 37
7.3 5EU 38
7.4 Japan/China 39
8 Appendix 42
8.1 Sources 43
8.2 Methodology 45
8.3 Key Events Included in the Analysis 46
8.4 About the Authors 47
8.5 About GlobalData 50
8.6 Disclaimer 52

Severe Acute Respiratory Syndrome (SARS) Global Clinical Trials Review, H2, 2018

Severe Acute Respiratory Syndrome (SARS) Global Clinical Trials Review, H2, 2018The clinical trial report, Severe Acute Respiratory Syndrome (SARS) Global Clinical Trials Review, H2, 2018 provides an overview of Severe

USD 2500 View Report

Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) - Pipeline Review, H2 2018

Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) - Pipeline Review, H2 2018The latest Pharmaceutical and Healthcare disease pipeline guide Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) - Pipeline Review, H2

USD 2000 View Report

Acute Coronary Syndrome - Market Insight, Epidemiology and Market Forecast - 2027

DelveInsights Acute Coronary Syndrome - Market Insight, Epidemiology and Market Forecast - 2027 report provides a detailed analysis of the Acute Coronary Syndrome epidemiology and market outlook for

USD 6250 View Report

Acute Coronary Syndrome - Epidemiology Forecast to 2027

DelveInsights Acute Coronary Syndrome - Epidemiology Forecast, 2027 report provides a comprehensive analysis of the Acute Coronary Syndrome epidemiology, providing the historical and forecasted data for

USD 3250 View Report

Your are not allow to send sample request

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available